Evidence map›Paper›PMID 42761771›Full record

ArticleInternational journal of chronic obstructive pulmonary disease2026

Insights into the Follow-Up of Patients with COPD in Daily Practice: Results from a Spanish Delphi Consensus ("The SEGUIPOC Study").

Bernardino Alcázar-Navarrete, Marc Miravitlles, Juan Antonio Riesco, Juan José Soler-Cataluña, SEGUIPOC Study Group, SEGUIPOC Study Group (members by alphabetical order):, SEGUIPOC Study Group (members by alphabetical order):

Abstract read
In one paragraph

Article in International journal of chronic obstructive pulmonary disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Bernardino Alcázar-Navarrete *Pulmonology Department, Virgen de Las Nieves University Hospital, IBS.Granada, Granada, Spain.ORCID 0000-0003-2356-9366
Marc Miravitlles *Pneumology Department, University Hospital Vall d'Hebron/Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.ORCID 0000-0002-9850-9520
Juan Antonio Riesco *Centro de Investigación en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain.ORCID 0000-0002-7418-0759
Juan José Soler-Cataluña *Centro de Investigación en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain.ORCID 0000-0003-1134-0783
SEGUIPOC Study Group
SEGUIPOC Study Group (members by alphabetical order):
SEGUIPOC Study Group (members by alphabetical order):

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To develop a consensus document on how to follow-up patients with COPD in clinical practice in Spain. Methods: A qualitative, three-round Delphi survey was conducted in the framework of Spanish pneumologists attending COPD patients in routine daily practice. Participants completed a 35-item questionnaire on how to follow-up COPD patients, according to four sections: 1) assessment of the patient's clinical conditions, 2) therapeutical interventions, 3) frequency of follow-up visits, and 4) healthcare pathways. Consensus was defined if more than 70% of participants agree. Results: A total of 155 specialists in respiratory medicine (53% men; mean age 47 years) participated in the study (69% with more than 10 years of professional practice). More than 80% of participants agreed on the use of clinical practice guidelines but 81.9% considered that recommendations on follow-up should be more explicit. Assessment of lung function (FEV1), dyspnea, and exacerbations were the clinical variables that reached a higher level of consensus. Dyspnea values were reported as the main indicator to assess increased bronchodilation, and exacerbations were the most important to assess the use of inhaled corticosteroids. Follow-up of low-risk patients should be performed in the primary care setting, and patients should be visited every 12 months, whereas high‑risk patients should be monitored by pneumologists and including nursing visits. Conclusion: The participants agree that the guidelines should include more specific indications to define the follow-up of the COPD patient, and there is lack of evidence in many aspects. There is consensus on the importance of care to coordinate with nursing and primary care, but the protocols to follow and the working tasks for each healthcare setting remain unclear.

Indexed as

LungPractice Patterns, Physicians'Pulmonary Disease, Chronic ObstructivePulmonologistsAdultBronchodilator AgentsConsensusCritical PathwaysDelphi TechniqueDisease ProgressionFemaleForced Expiratory VolumeGuideline AdherenceHealth Care SurveysHumansMaleBronchodilator Agentschronic obstructive pulmonary diseaseexpert consensuspatient monitoringpneumologistsprimary care

Identifiers

PMID42761771
PMCPMC13587128

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.